Anna K. Bassil,Soren Beinke,Rabinder Kumar Prinjha
申请号：
US14953546
公开号：
US09446041B2
申请日:
2015.11.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
